Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-233180
Filing Date
2012-05-15
Accepted
2012-05-15 10:01:49
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d329492d10q.htm 10-Q 258642
2 CERTIFICATION d329492dex311.htm EX-31.1 9683
3 CERTIFICATION d329492dex312.htm EX-31.2 9676
4 CERTIFICATION d329492dex321.htm EX-32.1 5002
  Complete submission text file 0001193125-12-233180.txt   1271339

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mshl-20120331.xml EX-101.INS 134773
6 XBRL TAXONOMY EXTENSION SCHEMA mshl-20120331.xsd EX-101.SCH 8975
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mshl-20120331_cal.xml EX-101.CAL 22844
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mshl-20120331_def.xml EX-101.DEF 19285
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mshl-20120331_lab.xml EX-101.LAB 88696
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mshl-20120331_pre.xml EX-101.PRE 60137
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MARSHALL EDWARDS INC (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 12841520
SIC: 2834 Pharmaceutical Preparations